WO2003045358A1 - TRANSDERMALES THERAPEUTISCHES SYSTEM ZUR VERABREICHUNG VON 17α-ESTRADIOL - Google Patents
TRANSDERMALES THERAPEUTISCHES SYSTEM ZUR VERABREICHUNG VON 17α-ESTRADIOL Download PDFInfo
- Publication number
- WO2003045358A1 WO2003045358A1 PCT/EP2002/012683 EP0212683W WO03045358A1 WO 2003045358 A1 WO2003045358 A1 WO 2003045358A1 EP 0212683 W EP0212683 W EP 0212683W WO 03045358 A1 WO03045358 A1 WO 03045358A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- transdermal therapeutic
- therapeutic system
- estradiol
- active substance
- containing reservoir
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002356588A AU2002356588A1 (en) | 2001-11-24 | 2002-11-13 | TRANSDERMAL THERAPEUTICAL SYSTEM FOR THE ADMINISTRATION OF 17Alpha ESTRADIOL |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10157745.1 | 2001-11-24 | ||
DE10157745A DE10157745A1 (de) | 2001-11-24 | 2001-11-24 | Transdermales therapeutisches System zur Verabreichung von 17alpha-Estradiol |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003045358A1 true WO2003045358A1 (de) | 2003-06-05 |
Family
ID=7706887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/012683 WO2003045358A1 (de) | 2001-11-24 | 2002-11-13 | TRANSDERMALES THERAPEUTISCHES SYSTEM ZUR VERABREICHUNG VON 17α-ESTRADIOL |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR037405A1 (de) |
AU (1) | AU2002356588A1 (de) |
DE (1) | DE10157745A1 (de) |
TW (1) | TW200302100A (de) |
WO (1) | WO2003045358A1 (de) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987007138A1 (en) * | 1986-05-30 | 1987-12-03 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration |
EP0421454A2 (de) * | 1989-10-06 | 1991-04-10 | LTS Lohmann Therapie-Systeme GmbH & Co. KG | Oestrogenhaltiges Wirkstoffpflaster |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
WO2000045797A1 (en) * | 1999-02-02 | 2000-08-10 | Ortho-Mcneil Pharmaceutical, Inc. | Method of manufacture for transdermal matrices |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US33870A (en) * | 1861-12-03 | Improvement in preserving-vessels | ||
US5554601A (en) * | 1993-11-05 | 1996-09-10 | University Of Florida | Methods for neuroprotection |
AU6032696A (en) * | 1995-06-07 | 1996-12-30 | Cygnus Therapeutic Systems | Pressure sensitive acrylate adhesive composition cross-linke d with aluminum acetylacetonate and containing a drug having a reactive aromatic hydroxyl group |
GB9803539D0 (en) * | 1998-02-19 | 1998-04-15 | Arnold Adrian C | Cleaning apparatus |
DE19830651A1 (de) * | 1998-07-09 | 2000-01-13 | Lohmann Therapie Syst Lts | Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung |
-
2001
- 2001-11-24 DE DE10157745A patent/DE10157745A1/de not_active Withdrawn
-
2002
- 2002-11-13 AU AU2002356588A patent/AU2002356588A1/en not_active Abandoned
- 2002-11-13 WO PCT/EP2002/012683 patent/WO2003045358A1/de not_active Application Discontinuation
- 2002-11-21 TW TW091133964A patent/TW200302100A/zh unknown
- 2002-11-22 AR ARP020104496A patent/AR037405A1/es not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987007138A1 (en) * | 1986-05-30 | 1987-12-03 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
EP0421454A2 (de) * | 1989-10-06 | 1991-04-10 | LTS Lohmann Therapie-Systeme GmbH & Co. KG | Oestrogenhaltiges Wirkstoffpflaster |
WO2000045797A1 (en) * | 1999-02-02 | 2000-08-10 | Ortho-Mcneil Pharmaceutical, Inc. | Method of manufacture for transdermal matrices |
Also Published As
Publication number | Publication date |
---|---|
TW200302100A (en) | 2003-08-01 |
AU2002356588A1 (en) | 2003-06-10 |
DE10157745A1 (de) | 2003-06-26 |
AR037405A1 (es) | 2004-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60033426T2 (de) | Adhäsive zubereitungen | |
DE102006050558B4 (de) | Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution | |
EP0744944B1 (de) | Transdermale therapeutische systeme enthaltend sexualsteroide | |
EP0697860B1 (de) | Estradiolhaltiges transdermales therapeutisches system | |
EP2720748B1 (de) | Transdermales arzneimittelabgabesystem und verwendungsverfahren dafür | |
DE19728517C2 (de) | TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung | |
WO1994004157A1 (de) | Mittel zur transdermalen applikation enthaltend 3-keto-desogestrel | |
EP1003477B1 (de) | Transdermales therapeutisches system (tts) enthaltend ammoniogruppenhaltige (meth)acrylatpolymere zur verabreichung von levonorgestrel | |
WO2003077890A1 (de) | Hormonhaltiges transdermales therapeutisches system mit einem wirkstoffreservoir auf der basis von vinylacetat-vinylpyrrolidon-copolymer mit verbesserter kohäsion. | |
DE60101206T2 (de) | Transdermale verabreichung von lasofoxifen | |
DE60013431T2 (de) | Transdermale vorrichtung zur verabreichung von testosteron oder einem derivat davon | |
WO2005110358A2 (de) | Filmförmiges, oral zu verabreichendes arzneimittel, enthaltend estriol | |
TW200528073A (en) | Transdermal delivery of hormones without the need of penetration enhancers | |
EP1671626A1 (de) | Transdermales Pflaster mit Progesteron A-spezifischen Liganden (PRASL) als Wirkstoff | |
EP1093361B1 (de) | Steroidhaltiges pflaster, verfahren zu seiner herstellung und verwendung | |
WO2003045358A1 (de) | TRANSDERMALES THERAPEUTISCHES SYSTEM ZUR VERABREICHUNG VON 17α-ESTRADIOL | |
DE60011710T2 (de) | Transdermale Östrogen Agonist-Antagonist Therapie | |
DE10025971B4 (de) | Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung | |
EP0848620A1 (de) | Mittel zur transdermalen applikation enthaltend ester des 3-ketodegestrel | |
DE102008006791B4 (de) | Transdermales Therapeutisches System mit Harnstoff-Komponente und Verfahren zu dessen Herstellung | |
EP2613771A1 (de) | Transdermale therapeutische systeme mit kristallisationsinhibierender schutzfolie (release liner) | |
EP3829550B1 (de) | Transdermales therapeutisches system zur abgabe von scopolamin ohne membran | |
DE10025970C2 (de) | Estrogenhaltiges Pflaster mit einem Wirkstoffreservoir auf der Basis von Ethylcellulose und einem Ethylen-Vinylacetat-Vinylpyrrolidon-Copolymer und seine Verwendung | |
WO1995020392A1 (de) | MITTEL ZUR TRANSDERMALEN APPLIKATION ENTHALTEND 14α,17α-ETHANOESTRA-1,3,5(10)-TRIEN-3,17β-DIOL | |
WO2020064494A1 (de) | Transdermales therapeutisches system mit barriereschicht |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BG BR BY CA CN CO CZ EE HR HU ID IL IN JP KP KR LT LV MX NO NZ PH PL RO RU SG SI SK TR UA US YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002803772 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200403030 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 532543 Country of ref document: NZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002803772 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |